HIGHLIGHTS
- who: Daniel Cook from the National Cancer Institute at Frederick (NIH), United States Gujarat University, India have published the research: Next generation immuno-oncology tumor profiling using a rapid, non-invasive, computational biophysics biomarker in early-stage breast cancer, in the Journal: (JOURNAL)
- what: The authors describe an IO response biomarker termed TumorIO that is derived from an in silico training methodology, taking advantage of mathematical modeling strategies to characterize in_vivo tumor activity . In the design stage of the study, the authors analyzed publiclyavailable single-cell_RNA_sequencing (scRNA-seq) data from ER+ and triple negative breast . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.